Novelix Pharmaceuticals Holds 32nd AGM, Approves Financials

Novelix Pharmaceuticals Limited conducted its 32nd Annual General Meeting (AGM) on September 30, 2026, via Video Conferencing. The meeting successfully transacted business electronically, including the adoption of standalone financial statements for the year ended March 31, 2026. Shareholders approved the financial statements and re-appointed a director retiring by rotation. Additionally, Mr. Gnana Prakash Gattu was appointed as Whole Time Director. The company submitted the combined voting results and the consolidated scrutinizer's report as per SEBI regulations.